YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy) | Zendy

Junya Aoki | Zendy; Kazumi Kimura | Zendy; Naomi Morita | Zendy; Masafumi Harada | Zendy; Norifumi Metoki | Zendy; Yohei Tateishi | Zendy; Kenichi Todo | Zendy; Hiroshi Yamagami | Zendy; Kouji Hayashi | Zendy; Yuka Terasawa | Zendy; Koji Fujita | Zendy; Nobuaki Yamamoto | Zendy; Ichiro Deguchi | Zendy; Norio Tanahashi | Zendy; Takeshi Inoue | Zendy; Takeshi Iwanaga | Zendy; Nobuyuki Kaneko | Zendy; Hidetaka Mitsumura | Zendy; Yasuyuki Iguchi | Zendy; Yasushi Ueno | Zendy; Yoji Kuramoto | Zendy; Toshiyasu Ogata | Zendy; Shigeru Fujimoto | Zendy; Mutsumi Yokoyama | Zendy; Shinji Nagahiro | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy)

Author(s) -

Junya Aoki,

Kazumi Kimura,

Naomi Morita,

Masafumi Harada,

Norifumi Metoki,

Yohei Tateishi,

Kenichi Todo,

Hiroshi Yamagami,

Kouji Hayashi,

Yuka Terasawa,

Koji Fujita,

Nobuaki Yamamoto,

Ichiro Deguchi,

Norio Tanahashi,

Takeshi Inoue,

Takeshi Iwanaga,

Nobuyuki Kaneko,

Hidetaka Mitsumura,

Yasuyuki Iguchi,

Yasushi Ueno,

Yoji Kuramoto,

Toshiyasu Ogata,

Shigeru Fujimoto,

Mutsumi Yokoyama,

Shinji Nagahiro

Publication year - 2017

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.015042

Subject(s) - medicine , plasminogen activator , edaravone , tissue plasminogen activator , combination therapy , tenecteplase , thrombolysis , surgery , myocardial infarction

We investigated whether administration of edaravone, a free radical scavenger, before or during tissue-type plasminogen activator (tPA) can enhance early recanalization in a major arterial occlusion.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research